Exhibit 5.1
| | | | |
| | 200 Clarendon Street Boston, Massachusetts 02116 Tel: +1.617.948.6000 Fax: +1.617.948.6001 www.lw.com |
| |
![LOGO](https://capedge.com/proxy/8-K/0001193125-18-233147/g544738graa.jpg) | | FIRM / AFFILIATE OFFICES |
| | Beijing | | Moscow |
| | Boston | | Munich |
| | Brussels | | New York |
| | Century City | | Orange County |
| | Chicago | | Paris |
| | Dubai | | Riyadh |
July 31, 2018 | | Düsseldorf | | Rome |
| | Frankfurt | | San Diego |
| | Hamburg | | San Francisco |
| | Hong Kong | | Seoul |
| | Houston | | Shanghai |
| | London | | Silicon Valley |
| | Los Angeles | | Singapore |
| | Madrid | | Tokyo |
| | Milan | | Washington, D.C. |
ContraFect Corporation
28 Wells Avenue, Third Floor
Yonkers, New York 10701
Re: | Registration Statement on FormS-3 (No.333-217989) |
Ladies and Gentlemen:
We have acted as special counsel to ContraFect Corporation, a Delaware corporation (the “Company”), in connection with the proposed issuance of 5,000,000 shares (the “Shares”) of common stock, par value $0.0001 per share, pursuant to a registration statement on FormS-3 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on May 12, 2017 (FileNo. 333-217989), including the information deemed to be a part of the registration statement pursuant to Rule 430B of the Act (as so filed, the “Registration Statement”), a base prospectus dated May 25, 2017 (the “Base Prospectus”), a preliminary prospectus supplement dated July 26, 2018 filed with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the “Preliminary Prospectus”), and a prospectus supplement dated July 27, 2018 filed with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the “Prospectus”). The Shares are being sold pursuant to an underwriting agreement dated July 27, 2018 by and between Piper Jaffray & Co., as representative of the several underwriters listed onSchedule I thereto, and the Company (the “Underwriting Agreement”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of RegulationS-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, the Preliminary Prospectus or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the “DGCL”), and we express no opinion with respect to any other laws.